Dandan Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dandan Zheng has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Hongxing Shen
Department of Spine Surgery, Renji Hospital
2 shared publications- Wenguo Cui
Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases, Department of Orthopaedics Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
2 shared publications - Andrea Hodgson
Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland
1 shared publication Bangbao Tao
Department of Neurosurgery, Xinhua Hospital School of Medicine
1 shared publicationCunxian Duan
Department of Pharmaceutics, College of Pharmacy, Shandong University, 44 Wenhua Xilu, Jinan 250012, PR China
1 shared publication- Cynthia L. Sears
Bloomberg ~ Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine
1 shared publication
Latest Publications
- 12 February 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (37)
Immuno‐Training Remodeled Vascular Microenvironment via Peptide‐Functionalized Hydrogel Microspheres for Neural Repair
The vascular hyperinflammatory microenvironment significantly influences the regeneration and repair of central nervous system (CNS) following injury. Training immune behavior of immune cells under stress conditions is crucial for maintaining vascular microenvironment homeostasis and restoring vascular function. In this study, we engineer a novel hyperinflammatory regulatory peptide (mND13) by rational grafting of a DJ‐1‐derived peptide with an MMP‐2 responsive peptide motif. This modified peptide is further conjugated onto hyaluronic acid methacrylate (HAMA) microspheres via photo‐click chemistry and microfluidic technology, generating mND13@HAMA microspheres. This platform induces microglia immuno‐training, inhibits their pro‐inflammatory polarization, thus orchestrating neurovascular niche remodeling and promoting neural recovery through immune‐vascular crosstalk. Both in vitro and in vivo investigations show that these immune‐functionalized peptide microspheres mND13@HAMA drastically decrease endothelial cell apoptosis and the expression of pro‐inflammatory molecules like iNOS, CD86 and IL‐1β in microglia. To further enhance post‐stroke angiogenesis, we co‐deliver VEGF liposomes with mND13@HAMA, which is proven to promote vascular sprouting and growth while inhibiting vascular apoptosis. This combined system markedly reduces brain atrophy volume in stroke mouse, improves neurobehavioral functions, and enhances angiogenesis. In conclusion, this immunomodulatory microsphere, capable of training immune cell behavior, holds significant therapeutic value for treating stroke along with other CNS injuries.
- 12 February 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (37)
Immuno‐Training Remodeled Vascular Microenvironment via Peptide‐Functionalized Hydrogel Microspheres for Neural Repair
The vascular hyperinflammatory microenvironment significantly influences the regeneration and repair of central nervous system (CNS) following injury. Training immune behavior of immune cells under stress conditions is crucial for maintaining vascular microenvironment homeostasis and restoring vascular function. In this study, we engineer a novel hyperinflammatory regulatory peptide (mND13) by rational grafting of a DJ‐1‐derived peptide with an MMP‐2 responsive peptide motif. This modified peptide is further conjugated onto hyaluronic acid methacrylate (HAMA) microspheres via photo‐click chemistry and microfluidic technology, generating mND13@HAMA microspheres. This platform induces microglia immuno‐training, inhibits their pro‐inflammatory polarization, thus orchestrating neurovascular niche remodeling and promoting neural recovery through immune‐vascular crosstalk. Both in vitro and in vivo investigations show that these immune‐functionalized peptide microspheres mND13@HAMA drastically decrease endothelial cell apoptosis and the expression of pro‐inflammatory molecules like iNOS, CD86 and IL‐1β in microglia. To further enhance post‐stroke angiogenesis, we co‐deliver VEGF liposomes with mND13@HAMA, which is proven to promote vascular sprouting and growth while inhibiting vascular apoptosis. This combined system markedly reduces brain atrophy volume in stroke mouse, improves neurobehavioral functions, and enhances angiogenesis. In conclusion, this immunomodulatory microsphere, capable of training immune cell behavior, holds significant therapeutic value for treating stroke along with other CNS injuries.
- 15 August 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (34) , 23566-23578
Active Magnesium Boride/Alginate Hydrogels Rejuvenate Senescent Cells
The clearance of senescent cells may be detrimental to low cell density diseases, such as intervertebral disc degeneration (IVDD), and rejuvenating these cells presents a formidable obstacle. In this study, we investigate a mild-alkalization strategy employing magnesium boride-alginate (MB-ALG) hydrogels to rejuvenate senescent cells associated with age-related diseases. MB-ALG hydrogels proficiently ensnare senescent cells owing to their surface roughness. The hydrolysis of MB-ALG hydrogels liberates hydroxide ions (OH-), effecting a transition from an acidic microenvironment (pH ∼ 6.2) to a mildly alkaline state (pH ∼ 8.0), thereby fostering senescent cell proliferation via activation of the PI3K/Akt/mTOR pathway. Additionally, H2 aids in ROS clearance, which reduces cellular oxidative stress. And, Mg2+ rejuvenates senescent cells by inhibiting Ca2+ influx and fine-tuning the sirt1-p53 signaling pathways. Both in vitro and in vivo experiments conducted on rat intervertebral discs corroborate the sustained antisenescence and rejuvenation properties of MB-ALG hydrogels, with effects persisting for up to 12 weeks postoperation. These discoveries elucidate the role of mild-alkalization in dictating cellular destiny and provide key insights for addressing age-related diseases.
- 15 August 2024
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 18 (34) , 23566-23578
Active Magnesium Boride/Alginate Hydrogels Rejuvenate Senescent Cells
The clearance of senescent cells may be detrimental to low cell density diseases, such as intervertebral disc degeneration (IVDD), and rejuvenating these cells presents a formidable obstacle. In this study, we investigate a mild-alkalization strategy employing magnesium boride-alginate (MB-ALG) hydrogels to rejuvenate senescent cells associated with age-related diseases. MB-ALG hydrogels proficiently ensnare senescent cells owing to their surface roughness. The hydrolysis of MB-ALG hydrogels liberates hydroxide ions (OH-), effecting a transition from an acidic microenvironment (pH ∼ 6.2) to a mildly alkaline state (pH ∼ 8.0), thereby fostering senescent cell proliferation via activation of the PI3K/Akt/mTOR pathway. Additionally, H2 aids in ROS clearance, which reduces cellular oxidative stress. And, Mg2+ rejuvenates senescent cells by inhibiting Ca2+ influx and fine-tuning the sirt1-p53 signaling pathways. Both in vitro and in vivo experiments conducted on rat intervertebral discs corroborate the sustained antisenescence and rejuvenation properties of MB-ALG hydrogels, with effects persisting for up to 12 weeks postoperation. These discoveries elucidate the role of mild-alkalization in dictating cellular destiny and provide key insights for addressing age-related diseases.
- Top Cited Papers
- 6 December 2023
- Published by Wiley in Advanced Materials
- Vol. 36 (5) , e2306105
Hydrogen Ion Capturing Hydrogel Microspheres for Reversing Inflammaging
Inflammaging is deeply involved in aging‐related diseases and can be destructive during aging. The maintenance of pH balance in the extracellular microenvironment can alleviate inflammaging and repair aging‐related tissue damage. In this study, the hydrogen ion capturing hydrogel microsphere (GMNP) composed of mineralized transforming growth factor‐β (TGF‐β) and catalase (CAT) nanoparticles is developed via biomimetic mineralization and microfluidic technology for blocking the NLRP3 cascade axis in inflammaging. This GMNP can neutralize the acidic microenvironment by capturing excess hydrogen ions through the calcium carbonate mineralization layer. Then, the subsequent release of encapsulated TGF‐β and CAT can eliminate both endogenous and exogenous stimulus of NLRP3, thus suppressing the excessive activation of inflammaging. In vitro, GMNP can suppress the excessive activation of the TXNIP/NLRP3/IL‐1β cascade axis and enhance extracellular matrix (ECM) synthesis in nucleus pulposus cells. In vivo, GMNP becomes a sustainable and stable niche with microspheres as the core to inhibit inflammaging and promote the regeneration of degenerated intervertebral discs. Therefore, this hydrogen ion‐capturing hydrogel microsphere effectively reverses inflammaging by interfering with the excessive activation of NLRP3 in the degenerated tissues.
- 6 December 2023
- Published by Wiley in Advanced Materials
- Vol. 36 (5) , e2306105
Top Cited PapersHydrogen Ion Capturing Hydrogel Microspheres for Reversing Inflammaging
Inflammaging is deeply involved in aging‐related diseases and can be destructive during aging. The maintenance of pH balance in the extracellular microenvironment can alleviate inflammaging and repair aging‐related tissue damage. In this study, the hydrogen ion capturing hydrogel microsphere (GMNP) composed of mineralized transforming growth factor‐β (TGF‐β) and catalase (CAT) nanoparticles is developed via biomimetic mineralization and microfluidic technology for blocking the NLRP3 cascade axis in inflammaging. This GMNP can neutralize the acidic microenvironment by capturing excess hydrogen ions through the calcium carbonate mineralization layer. Then, the subsequent release of encapsulated TGF‐β and CAT can eliminate both endogenous and exogenous stimulus of NLRP3, thus suppressing the excessive activation of inflammaging. In vitro, GMNP can suppress the excessive activation of the TXNIP/NLRP3/IL‐1β cascade axis and enhance extracellular matrix (ECM) synthesis in nucleus pulposus cells. In vivo, GMNP becomes a sustainable and stable niche with microspheres as the core to inhibit inflammaging and promote the regeneration of degenerated intervertebral discs. Therefore, this hydrogen ion‐capturing hydrogel microsphere effectively reverses inflammaging by interfering with the excessive activation of NLRP3 in the degenerated tissues.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Data from Bacterial Genotoxin Accelerates Transient Infection–Driven Murine Colon Tumorigenesis
Chronic and low-grade inflammation associated with persistent bacterial infections has been linked to colon tumor development; however, the impact of transient and self-limited infections in bacterially driven colon tumorigenesis has remained enigmatic. Here we report that UshA is a novel genotoxin in attaching/effacing (A/E) pathogens, which include the human pathogens enteropathogenic Escherichia coli, enterohemorrhagic E. coli, and their murine equivalent Citrobacter rodentium (CR). UshA harbors direct DNA digestion activity with a catalytic histidine–aspartic acid dyad. Injected via the type III secretion system (T3SS) into host cells, UshA triggers DNA damage and initiates tumorigenic transformation during infections in vitro and in vivo. Moreover, UshA plays an indispensable role in CR infection–accelerated colon tumorigenesis in genetically susceptible ApcMinΔ716/+ mice. Collectively, our results reveal that UshA, functioning as a bacterial T3SS-dependent genotoxin, plays a critical role in prompting transient and noninvasive bacterial infection–accelerated colon tumorigenesis in mice.Significance:We identified UshA, a novel T3SS-dependent genotoxin in A/E pathogens that possesses direct DNA digestion activity and confers bacterially accelerated colon tumorigenesis in mice. Our results demonstrate that acute and noninvasive infection with A/E pathogens harbors a far-reaching impact on the development of colon cancer.This article is highlighted in the In This Issue feature, p. 1
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Bacterial Genotoxin Accelerates Transient Infection–Driven Murine Colon Tumorigenesis
Chronic and low-grade inflammation associated with persistent bacterial infections has been linked to colon tumor development; however, the impact of transient and self-limited infections in bacterially driven colon tumorigenesis has remained enigmatic. Here we report that UshA is a novel genotoxin in attaching/effacing (A/E) pathogens, which include the human pathogens enteropathogenic Escherichia coli, enterohemorrhagic E. coli, and their murine equivalent Citrobacter rodentium (CR). UshA harbors direct DNA digestion activity with a catalytic histidine–aspartic acid dyad. Injected via the type III secretion system (T3SS) into host cells, UshA triggers DNA damage and initiates tumorigenic transformation during infections in vitro and in vivo. Moreover, UshA plays an indispensable role in CR infection–accelerated colon tumorigenesis in genetically susceptible ApcMinΔ716/+ mice. Collectively, our results reveal that UshA, functioning as a bacterial T3SS-dependent genotoxin, plays a critical role in prompting transient and noninvasive bacterial infection–accelerated colon tumorigenesis in mice.Significance:We identified UshA, a novel T3SS-dependent genotoxin in A/E pathogens that possesses direct DNA digestion activity and confers bacterially accelerated colon tumorigenesis in mice. Our results demonstrate that acute and noninvasive infection with A/E pathogens harbors a far-reaching impact on the development of colon cancer.This article is highlighted in the In This Issue feature, p. 1
- 2 November 2011
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 29 (2) , 194-203
Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery
It is reported that the nanosuspension is one of the promising formulations for poorly water-soluble drugs. In order to enhance the in vitro and in vivo behaviours of DDB (bifendate), DDB-NSP (DDB nanosuspensions) have been produced by the precipitation-combined microfluidization method. The optimized DDB-NSP were transformed into dry powders by freeze-drying and then investigated by transmission electron microscopy, laser diffraction and X-ray diffraction (XRD) experiments. Next, the pharmacokinetics and biodistribution of DDB-NSP and DDB-Sol (DDB solution) were carried out. XRD experiments manifested that the crystalline state of DDB was preserved after the size reduction process. An accelerated dissolution velocity and increased saturation solubility could be shown for the DDB-NSP. Compared with DDB-Sol, DDB-NSP exhibited a markedly different pharmacokinetic property with a 17.18-fold increase in AUC0–∞. Meanwhile, the tissue distribution demonstrated that DDB-NSP were mainly uptaken by RES organs particularly by liver. These results supported the fact that nanosuspension, as a promising intravenous drug-delivery system for DDB, could be developed as an alternative to the conventional DDB preparations.
- 2 November 2011
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 29 (2) , 194-203
Studies on pharmacokinetics and tissue distribution of bifendate nanosuspensions for intravenous delivery
It is reported that the nanosuspension is one of the promising formulations for poorly water-soluble drugs. In order to enhance the in vitro and in vivo behaviours of DDB (bifendate), DDB-NSP (DDB nanosuspensions) have been produced by the precipitation-combined microfluidization method. The optimized DDB-NSP were transformed into dry powders by freeze-drying and then investigated by transmission electron microscopy, laser diffraction and X-ray diffraction (XRD) experiments. Next, the pharmacokinetics and biodistribution of DDB-NSP and DDB-Sol (DDB solution) were carried out. XRD experiments manifested that the crystalline state of DDB was preserved after the size reduction process. An accelerated dissolution velocity and increased saturation solubility could be shown for the DDB-NSP. Compared with DDB-Sol, DDB-NSP exhibited a markedly different pharmacokinetic property with a 17.18-fold increase in AUC0–∞. Meanwhile, the tissue distribution demonstrated that DDB-NSP were mainly uptaken by RES organs particularly by liver. These results supported the fact that nanosuspension, as a promising intravenous drug-delivery system for DDB, could be developed as an alternative to the conventional DDB preparations.